{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:54:03Z","timestamp":1791222843982,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T00:00:00Z","timestamp":1426032000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12985-015-0273-9","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T23:48:22Z","timestamp":1425944902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["High level of HIV-1 drug resistance among patients with HIV-1 and HIV-1\/2 dual infections in Guinea-Bissau"],"prefix":"10.1186","volume":"12","author":[{"name":"for The Bissau HIV cohort study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Jespersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Tolstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Langhoff","family":"H\u00f8nge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candida","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David da Silva","family":"T\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svend","family":"Ellermann-Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wejse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Lund","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,11]]},"reference":[{"key":"273_CR1","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","volume":"380","author":"RK Gupta","year":"2012","unstructured":"Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, Gregson J, et al. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet. 2012;380:1250\u20138.","journal-title":"Lancet"},{"key":"273_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/QAI.0b013e318227fc34","volume":"58","author":"KC Sigaloff","year":"2011","unstructured":"Sigaloff KC, Hamers RL, Wallis CL, Kityo C, Siwale M, Ive P, et al. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. J Acquir Immune Defic Syndr. 2011;58:23\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"273_CR3","doi-asserted-by":"publisher","first-page":"e13414","DOI":"10.1371\/journal.pone.0013414","volume":"5","author":"A Pasquet","year":"2010","unstructured":"Pasquet A, Messou E, Gabillard D, Minga A, Depoulosky A, Deuffic-Burban S, et al. Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan. Cote d\u2019Ivoire PLoS One. 2010;5:e13414.","journal-title":"Cote d\u2019Ivoire PLoS One"},{"key":"273_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/jama.300.5.530","volume":"300","author":"A Boulle","year":"2008","unstructured":"Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, et al. Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy. JAMA. 2008;300:530\u20139.","journal-title":"JAMA"},{"key":"273_CR5","volume-title":"CONSOLIDATED GUIDELINES on the use of ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION","author":"WHO","year":"2013","unstructured":"WHO. CONSOLIDATED GUIDELINES on the use of ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION. 2013. http:\/\/apps.who.int\/iris\/bitstream\/10665\/85321\/1\/9789241505727_eng.pdf?ua=1 . Accessed 24 Febr 2015."},{"key":"273_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/01213011-200512000-00004","volume":"15","author":"K Klein","year":"2005","unstructured":"Klein K, Lang T, Saussele T, Barbosa-Sicard E, Schunck WH, Eichelbaum M, et al. Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz. Pharmacogenet Genomics. 2005;15:861\u201373.","journal-title":"Pharmacogenet Genomics"},{"key":"273_CR7","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/QAD.0b013e328300a33d","volume":"22","author":"ZJ Da Silva","year":"2008","unstructured":"Da Silva ZJ, Oliveira I, Andersen A, Dias F, Rodrigues A, Holmgren B, et al. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? AIDS. 2008;22:1195\u2013202.","journal-title":"AIDS"},{"key":"273_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/00002030-199308000-00015","volume":"7","author":"A Wilkins","year":"1993","unstructured":"Wilkins A, Ricard D, Todd J, Whittle H, Dias F, Paulo Da Silva A. The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS. 1993;7:1119\u201322.","journal-title":"AIDS"},{"key":"273_CR9","first-page":"941","volume":"6","author":"AG Poulsen","year":"1993","unstructured":"Poulsen AG, Aaby P, Gottschau A, Kvinesdal BB, Dias F, Molbak K, et al. HIV-2 infection in Bissau, West Africa, 1987\u20131989: incidence, prevalences, and routes of transmission. J Acquir Immune Defic Syndr. 1993;6:941\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"273_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/135965350400900115","volume":"9","author":"M Witvrouw","year":"2004","unstructured":"Witvrouw M, Pannecouque C, Switzer WM, Folks TM, De Clercq E, Heneine W. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. Antivir Ther. 2004;9:57\u201365.","journal-title":"Antivir Ther"},{"key":"273_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1128\/JCM.02452-12","volume":"51","author":"M Thiam","year":"2013","unstructured":"Thiam M, Diop-Ndiaye H, Diouf AD, Vidal N, Ndiaye O, Ndiaye I, et al. HIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system. J Clin Microbiol. 2013;51:578\u201384.","journal-title":"J Clin Microbiol"},{"key":"273_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3851\/IMP1754","volume":"16","author":"C Charpentier","year":"2011","unstructured":"Charpentier C, Bellecave P, Cisse M, Mamadou S, Diakite M, Peytavin G, et al. High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger. Antivir Ther. 2011;16:429\u201333.","journal-title":"Antivir Ther"},{"key":"273_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1089\/aid.2009.0295","volume":"26","author":"H Diop-Ndiaye","year":"2010","unstructured":"Diop-Ndiaye H, Toure-Kane C, Leye N, Ngom-Gueye NF, Montavon C, Peeters M, et al. Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal. AIDS Res Hum Retroviruses. 2010;26:1133\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"273_CR14","first-page":"201","volume":"22","author":"S Jespersen","year":"2014","unstructured":"Jespersen S, Honge BL, Oliveira I, Medina C, Da Silva Te D, Correira FG, et al. Cohort profile: the Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients. Int J Epidemiol. 2014;22:201.","journal-title":"Int J Epidemiol"},{"key":"273_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/QAI.0b013e3182a97b81","volume":"65","author":"BL Honge","year":"2014","unstructured":"Honge BL, Bjarnason Obinah MP, Jespersen S, Medina C, Te Dda S, Da Silva ZJ, et al. Performance of 3 rapid tests for discrimination between HIV-1 and HIV-2 in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr. 2014;65:87\u201390.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"273_CR16","volume-title":"Stanford HIV RT and protease sequence database","author":"R Shafer","year":"2014","unstructured":"Shafer R. Stanford HIV RT and protease sequence database. 2014. http:\/\/hivdb.stanford.edu ; Accessed 24 Febr 2015."},{"key":"273_CR17","unstructured":"WHO. HIV Drug Resistance Report 2012. http:\/\/apps.who.int\/iris\/bitstream\/10665\/75183\/1\/9789241503938_eng.pdf ; Accessed 24 Febr 2015."},{"key":"273_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1473-3099(09)70328-7","volume":"10","author":"RE Barth","year":"2010","unstructured":"Barth RE, van der Loeff MF, Schuurman R, Hoepelman AI, Wensing AM. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2010;10:155\u201366.","journal-title":"Lancet Infect Dis"},{"key":"273_CR19","doi-asserted-by":"publisher","first-page":"e17025","DOI":"10.1371\/journal.pone.0017025","volume":"6","author":"J Esbjornsson","year":"2011","unstructured":"Esbjornsson J, Mild M, Mansson F, Norrgren H, Medstrand P. HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations. PLoS One. 2011;6:e17025.","journal-title":"PLoS One"},{"key":"273_CR20","doi-asserted-by":"publisher","first-page":"F9","DOI":"10.1097\/01.aids.0000232228.88511.0b","volume":"20","author":"BG Brenner","year":"2006","unstructured":"Brenner BG, Oliveira M, Doualla-Bell F, Moisi DD, Ntemgwa M, Frankel F, et al. HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. AIDS. 2006;20:F9\u201313.","journal-title":"AIDS"},{"key":"273_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcv.2004.03.015","volume":"31","author":"A Holguin","year":"2004","unstructured":"Holguin A, Paxinos E, Hertogs K, Womac C, Soriano V. Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes. J Clin Virol. 2004;31:215\u201320.","journal-title":"J Clin Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-015-0273-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0273-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0273-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T15:48:12Z","timestamp":1651420092000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-015-0273-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,11]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1186\/s12985-015-0273-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,11]]},"assertion":[{"value":"25 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}